Durch KI Einsatz in der Wirkstoffforschung und klinischen Studien,
Produktivität steigern, 'time to market' beschleunigen und Kosten senken.

September 01 - 03, 2025 | Palace Hotel Berlin, Germany

Agenda

Werden Sie Sponsor

Jetzt Buchen

Nikola Milosevic

Science Fellow Bayer AG

Nikola Milosevic holds a PhD in computer science from the University of Manchester. He held several academic and industry positions before joining Bayer in 2020. In Bayer, Nikola was working on internal search engines, knowledge graps and generative AI use-cases, developing set of frameworks and tools.

2. Konferenztag, 03. September 2025

1:50 PM Target discovery using GenAI, knowledge graphs and literature

-We have developed systems based on GenAI to rank and explain targets

-The system is based on literature, clinical trial documents, and knowledge graph

-Current state-of-the-art LLMs are able to analyze multi-modal data and provide comprehensive evaluation of the targets

-Pipeline can produce in few hours comprehensive summary of possible targets for a disease

Check out the incredible speaker line-up to see who will be joining Nikola.

Download The Latest Agenda

In Partnership With:

Connect With Us

Questions?

Tel: +49 30 52001534

E-mail: eq@iqpc.de

Imprint:
Company information according to § 5 Telemediengesetz
IQPC Gesellschaft für Management Konferenzen mbH
Address: Rosenstrasse 2, 10178 Berlin, Germany
Tel: 49 30 52 001 534
E-mail: info@iqpc.de
Registered at: Amtsgericht Charlottenburg, HRB 76720
VAT-Number: DE210454451
Management: Torben Haagh, Richard A. Worden, Michael R. Worden